$DLXY

Delixy Holdings Ltd

No enriched coverage for $DLXY in the last 7 days.

No SEC Form 4 filings for $DLXY in the last 30 days.

Med

Delixy Holdings Limited Reports Fiscal Year 2025 Financial Results

Delixy Holdings Limited reported its financial results for fiscal year 2025, showing a net loss of $4.5 million compared to a net income of $1.0 million in fiscal year 2024, despite a slight revenue decline. The company attributes the loss primarily to $4.9 million in consulting and advisory fees incurred at the holding company level for growth initiatives, while its core oil trading subsidiary remained profitable. Delixy plans to diversify its product portfolio into LNG and LPG to strengthen its market position and revenue streams.

Delixy Holdings Warned by Nasdaq Over Minimum Bid Price Deficiency

Delixy Holdings Limited received a notice from Nasdaq for failing to meet the minimum US$1.00 bid price requirement for 30 consecutive business days. The company has until October 20, 2026, to regain compliance and is considering options like a reverse stock split to avoid potential delisting. Spark, TipRanks’ AI Analyst, rates DLXY as Neutral, citing high leverage and a drop in operating cash flow despite a modest revenue rebound.

Delixy Holdings Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Delixy Holdings Limited announced it received a Nasdaq notification for not meeting the minimum bid price requirement of US$1.00 per share, based on its Class A ordinary shares' closing bid price from March 11 to April 22, 2026. The company has until October 20, 2026, to regain compliance by maintaining a closing bid price of at least US$1.00 for ten consecutive business days. Delixy is monitoring its share price and may consider options like a reverse stock split to address the deficiency.